Header

UZH-Logo

Maintenance Infos

Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni


Meister, Isabel; Ingram-Sieber, Katrin; Cowan, Noemi; Todd, Matthew H; Robertson, Murray N; Meli, Claudia; Patra, Malay; Gasser, Gilles; Keiser, Jennifer (2014). Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni. Antimicrobial Agents and Chemotherapy, 58(9):5466-5472.

Abstract

A racemic mixture of R and S enantiomers of praziquantel (PZQ) is currently the treatment of choice for schistosomiasis. Though the S enantiomer and the metabolites are presumed to contribute only a little to the activity of the drug, in-depth side-by-side studies are lacking. The aim of this study was to investigate the in vitro activities of PZQ and its main metabolites, namely, R- and S-cis- and R- and S-trans-4'-hydroxypraziquantel, against adult worms and newly transformed schistosomula (NTS). Additionally, we explored the in vivo activity and hepatic shift (i.e., the migration of the worms to the liver) produced by each PZQ enantiomer in mice. Fifty percent inhibitory concentrations of R-PZQ, S-PZQ, and R-trans- and R-cis-4'-hydroxypraziquantel of 0.02, 5.85, 4.08, and 2.42 μg/ml, respectively, for adult S. mansoni were determined in vitro. S-trans- and S-cis-4'-hydroxypraziquantel were not active at 100 μg/ml. These results are consistent with microcalorimetry data and studies with NTS. In vivo, single 400-mg/kg oral doses of R-PZQ and S-PZQ achieved worm burden reductions of 100 and 19%, respectively. Moreover, worms treated in vivo with S-PZQ displayed an only transient hepatic shift and returned to the mesenteric veins within 24 h. Our data confirm that R-PZQ is the main effector molecule, while S-PZQ and the metabolites do not play a significant role in the antischistosomal properties of PZQ.

Abstract

A racemic mixture of R and S enantiomers of praziquantel (PZQ) is currently the treatment of choice for schistosomiasis. Though the S enantiomer and the metabolites are presumed to contribute only a little to the activity of the drug, in-depth side-by-side studies are lacking. The aim of this study was to investigate the in vitro activities of PZQ and its main metabolites, namely, R- and S-cis- and R- and S-trans-4'-hydroxypraziquantel, against adult worms and newly transformed schistosomula (NTS). Additionally, we explored the in vivo activity and hepatic shift (i.e., the migration of the worms to the liver) produced by each PZQ enantiomer in mice. Fifty percent inhibitory concentrations of R-PZQ, S-PZQ, and R-trans- and R-cis-4'-hydroxypraziquantel of 0.02, 5.85, 4.08, and 2.42 μg/ml, respectively, for adult S. mansoni were determined in vitro. S-trans- and S-cis-4'-hydroxypraziquantel were not active at 100 μg/ml. These results are consistent with microcalorimetry data and studies with NTS. In vivo, single 400-mg/kg oral doses of R-PZQ and S-PZQ achieved worm burden reductions of 100 and 19%, respectively. Moreover, worms treated in vivo with S-PZQ displayed an only transient hepatic shift and returned to the mesenteric veins within 24 h. Our data confirm that R-PZQ is the main effector molecule, while S-PZQ and the metabolites do not play a significant role in the antischistosomal properties of PZQ.

Statistics

Citations

18 citations in Web of Science®
20 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

188 downloads since deposited on 06 Nov 2014
42 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:07 Faculty of Science > Department of Chemistry
Dewey Decimal Classification:540 Chemistry
Language:English
Date:2014
Deposited On:06 Nov 2014 12:21
Last Modified:08 Dec 2017 07:59
Publisher:American Society for Microbiology
ISSN:0066-4804
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1128/AAC.02741-14
PubMed ID:24982093

Download

Download PDF  'Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni'.
Preview
Filetype: PDF (Fig. 1)
Size: 13kB
View at publisher
Download PDF  'Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni'.
Preview
Filetype: PDF (Fig. 2)
Size: 172kB
Download PDF  'Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni'.
Preview
Filetype: PDF (Fig. 3)
Size: 28kB
Download PDF  'Activity of Praziquantel Enantiomers and Main Metabolites Against Schistosoma mansoni'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 701kB